docetaxel anhydrous has been researched along with sphingosine 1-phosphate in 7 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (sphingosine 1-phosphate) | Trials (sphingosine 1-phosphate) | Recent Studies (post-2010) (sphingosine 1-phosphate) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 3,796 | 23 | 2,148 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | sphingosine 1-phosphate (IC50) |
|---|---|---|---|
| Sphingosine 1-phosphate receptor 2 | Homo sapiens (human) | 0.0019 | |
| Sphingosine 1-phosphate receptor 4 | Homo sapiens (human) | 0.0522 | |
| Sphingosine 1-phosphate receptor 1 | Homo sapiens (human) | 0.0008 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.023 | |
| Sphingosine 1-phosphate receptor 3 | Homo sapiens (human) | 0.0004 | |
| Sphingosine 1-phosphate receptor 5 | Homo sapiens (human) | 0.002 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Bonhoure, E; Calvet, C; Cuvillier, O; Doumerc, N; Garcia, V; Golzio, M; Malavaud, B; Mazerolles, C; Pchejetski, D; Rischmann, P; Teissié, J | 1 |
| Alcorn, J; Chen, L; Ling, B; Ma, B; Yang, J | 1 |
| Baran, Y; Bassoy, EY | 1 |
| Ader, I; Bocquet, M; Brizuela, L; Cuvillier, O; Malavaud, B; Mazerolles, C | 1 |
| Beckham, TH; Cheng, JC; Liu, X; Lu, P; Marrison, ST; Norris, JS | 1 |
| Becker, KA; Bieberich, E; Bielawski, J; Doolen, S; Goins, L; Gulbins, E; McQuerry, KJ; Spassieva, SD; Sure, U; Taylor, BK; Uerschels, AK | 1 |
| Abuhussein, O; Yang, J | 1 |
7 other study(ies) available for docetaxel anhydrous and sphingosine 1-phosphate
| Article | Year |
|---|---|
Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Camptothecin; Ceramides; Disease Models, Animal; Docetaxel; Flow Cytometry; Green Fluorescent Proteins; Humans; Lysophospholipids; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; RNA Interference; Sphingosine; Taxoids; Tumor Cells, Cultured | 2005 |
Sphingosine-1-phosphate: a potential therapeutic agent against human breast cancer.
Topics: Aldehyde-Lyases; Apoptosis; Breast Neoplasms; Cell Proliferation; Docetaxel; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Lysophospholipids; Phosphotransferases (Alcohol Group Acceptor); RNA, Messenger; Sphingosine; Taxoids | 2011 |
Bioactive sphingolipids in docetaxel-induced apoptosis in human prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Ceramides; Docetaxel; Down-Regulation; Drug Synergism; Gene Expression Regulation, Neoplastic; Glucosylceramides; Glucosyltransferases; Humans; Lysophospholipids; Male; Oxidoreductases; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Sphingosine; Taxoids; Up-Regulation | 2012 |
First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancer.
Topics: Adaptor Proteins, Signal Transducing; Aldehyde-Lyases; Antineoplastic Agents; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Docetaxel; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Lysophospholipids; Male; Neoplasm Grading; Prostate; Prostatic Neoplasms; Radiation Tolerance; RNA Interference; Sphingosine; Taxoids | 2012 |
Acid ceramidase promotes nuclear export of PTEN through sphingosine 1-phosphate mediated Akt signaling.
Topics: Acid Ceramidase; Active Transport, Cell Nucleus; Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cytoplasm; Docetaxel; Drug Resistance, Neoplasm; Exportin 1 Protein; Gene Expression Regulation, Neoplastic; Humans; Karyopherins; Lysophospholipids; Male; Mice; Neoplasm Transplantation; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Sphingosine; Taxoids | 2013 |
Role of 1-Deoxysphingolipids in docetaxel neurotoxicity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Axons; Ceramides; Docetaxel; Female; Ganglia, Spinal; Lipids; Lysophospholipids; Mice; Mice, Inbred C57BL; Neurotoxicity Syndromes; Sensory Receptor Cells; Serine; Serine C-Palmitoyltransferase; Sphingolipids; Sphingosine | 2020 |
Evaluating the antitumor activity of sphingosine-1-phosphate against human triple-negative breast cancer cells with basal-like morphology.
Topics: Antineoplastic Agents; Apoptosis; Breast; Cell Line, Tumor; Cell Proliferation; Cell Survival; Docetaxel; Drug Interactions; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lysophospholipids; Phosphotransferases (Alcohol Group Acceptor); Sphingosine; Sphingosine-1-Phosphate Receptors; Triple Negative Breast Neoplasms | 2020 |